logo
Accuracy of ECG-inclusive preparticipation screening in athletes: more work to be done
Should HDL cholesterol levels be the primary target of cardiovascular disease risk assessment and therapy?
Patient selection for transcatheter aortic valve replacement: what does the future hold?
Implantable cardiac electronic device infection: a growing danger?
High blood pressure may be less of a threat to cardiovascular health if it develops later in life
Transcatheter aortic valve replacement demonstrated suitable for patients with left ventricular dysfunction
Could vitamin D supplementation reduce blood pressure in hypertensive patients?
First fully biodegradable stent demonstrated to be safe for use in humans
A new pure ω-3 eicosapentaenoic acid ethyl ester (AMR101) for the management of hypertriglyceridemia: the MARINE trial
Insights from the RCPE UK Consensus Conference on approaching the comprehensive management of atrial fibrillation
Serum uric acid and pre-eclampsia: an update
Outcomes of carotid stenting among symptomatic patients: a contemporary review
The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond
Treatment of hypertension in diabetes: what is the best therapeutic option?
Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management
Diabetic cardiovascular autonomic neuropathy: clinical implications
Management and therapy for cardiomyopathy in Friedreich's ataxia
The older patient with heart failure: high risk for frailty and cognitive impairment
Adiposopathy and thyroid disease: tracing the pathway to cardiovascular risk
Nanomedicine in cardiovascular therapy: recent advancements
Acknowledgements